- Did you mean
- limitations
Search results - 1 result
Regulatory issues regarding manufacture and control of vaccine adjuvants. The EU situation.
should be taken into account by the regulatory assessors. At the level of batch control and release by official medicinal control laboratories (OMCL 's), the testing on adjuvants is very limited and ...